- Drug Improvement R&D
- R & D for the purpose of improving the effectiveness of existing licensed products,
such as switching drug delivery systems, new formulations, and expanding indications
- R&D at Pangyo
- Pipeline construction to secure quality competitiveness through intensive development of specific formulations and R&D of IMD
- Central Laboratory at Munmak
- Based on R&D investment, we have production facilities of various formulations, and carry out projects for optimal process development and securing original technology
- Union Korea Biological Science
- A life-science company with high growth potential and R&D capability for diagnosing of incurable diseases and R&D of drugs based on exosome and aptamer